Summary
Backgound
Improved antimicrobial stewardship, sanitation, and hygiene are WHO-inspired priorities for restriction of the spread of antimicrobial resistance. Prioritisation among these objectives is essential, particularly in low-income and middle-income countries, but the factors contributing most to antimicrobial resistance are typically unknown and could vary substantially between and within countries. We aimed to identify the biological and socioeconomic risk factors associated with carriage of resistant Escherichia coli in three culturally diverse ethnic groups in northern Tanzania.
Methods
We developed a survey containing more than 200 items and administered it in randomly selected households in 13 Chagga, Arusha, or Maasai villages chosen on the basis of ethnic composition and distance to urban centres. Human stool samples were collected from a subset of households, as were liquid milk samples and swabs of milk containers. Samples were processed and plated onto MacConkey agar plates, then presumptive E coli isolates were identified on the basis of colony morphology. Susceptibility of isolates was then tested against a panel of nine antimicrobials (ampicillin, ceftazidime, chloramphenicol, ciprofloxacin, kanamycin, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim) via a breakpoint assay. Susceptibility findings were matched with data across a wide range of household characteristics, including education, hygiene practices, wealth, livestock husbandry, and antibiotic use.
Findings
Between March 23, 2012, and July 30, 2015, we interviewed 391 households (118 Arusha, 100 Chagga, and 173 Maasai). Human stool samples were collected at 226 (58%) households across the 13 villages. 181 milk samples and 191 milk-container swabs were collected from 117 households across seven villages. 11 470 putative E coli samples were isolated from stool samples. Antimicrobial use in people and livestock was not associated with prevalence of resistance at the household level. Instead, the factors with the greatest predictive value involved exposure to bacteria, and were intimately connected with fundamental cultural differences across study groups. These factors included how different subsistence types (pastoralists vs farmers) access water sources and consumption of unboiled milk, reflecting increased exposure to resistant bacteria in milk.
Interpretation
When cultural and ecological conditions favour bacterial transmission, there is a high likelihood that people will harbour antimicrobial-resistant bacteria irrespective of antimicrobial use practices. Public health interventions to limit antimicrobial resistance need to be tailored to local practices that affect bacterial transmission.
Funding
US National Science Foundation; Biotechnology and Biological Sciences Research Council, UK Medical Research Council; and the Allen School.
Introduction
Antimicrobial use is the ultimate factor driving the emergence of antimicrobial resistance.1 This fact is the motivation for policies that are intended to reduce unnecessary antimicrobial use, which is often a focus of WHO-inspired national antimicrobial-resistance action plans around the world.2 The tangled interplay of antimicrobial use and microbial transmission between people, animals, and the environment complicates efforts to reduce antimicrobial resistance. These issues are likely to be most acute in low-income and middle-income countries, where laissez-faire access to, and use of, antimicrobials is frequently coupled with a high prevalence of infectious disease.3, 4 Although many studies have examined risk factors for antimicrobial resistance,2 they have typically focused on ultimate selective factors (eg, antimicrobial use, health-care-seeking behaviour) and have often been done in clinical contexts.1 Comprehensive examinations of a range of ultimate and proximate drivers of antimicrobial resistance at the community level have been done in only a few studies.5, 6, 7, 8, 9 To our knowledge, no studies have been published in which a cross-cultural sampling design was used to examine how factors can vary across communities—especially when these communities are likely to interact to some degree. This is a crucial information gap, particularly in low-income and middle-income countries, where communities collectively have an extraordinary diversity of socioeconomic systems that blend western and traditional medical belief systems and that operate within varying regulatory and health-care environments.
Research in context.
Evidence before this study
We searched PubMed and Google Scholar with the terms “antimicrobial resistance” OR “antibiotic resistance” AND “community” AND “risk factors” OR “correlates” for reports of studies done in low-income or lower-middle-income countries that combined household-level surveys with collection of biological samples from people published in English up to May 5, 2018. Our search identified five relevant studies. Two showed evidence that antimicrobial resistance was associated with antibiotic use. Other risk factors identified in the studies included hygiene practices such as handwashing and the availability of potable water sources, and socioeconomic factors including household wealth, household density, and maternal literacy. Combination of the findings from these five studies to compare effect sizes for the different risk factors is complicated, however, because of differences in both questionnaires (eg, some questionnaires seemed largely limited to questions about antibiotic use) and laboratory methods used to measure antimicrobial susceptibility. We did not find any studies in which a cross-cultural approach was explicitly used to examine risk factors for antimicrobial resistance.
Added value of this study
In this study, we combined extensive collection of bacterial isolates (more than 11 000) with collection of comprehensive data for household-level health and hygiene practices and socioeconomic characteristics. By using the same data-collection and data-analysis protocols across three culturally diverse ethnic groups, we were able to assess the relative contribution of livelihood dimensions (eg, animal husbandry practices, engagement with modern human and animal health sectors, hygiene practices) to community patterns of antibiotic resistance. In line with two previous studies, we found that antibiotic resistance in Escherichia coli was not significantly associated with antibiotic use. Instead, we showed that the prevalence of antibiotic-resistant E coli was associated with cultural–ecological factors that affect bacterial transmission, including how water is accessed and how milk is handled. Although studies have shown the presence of resistant pathogens in milk from households in low-income countries, to our knowledge, our study is the first to show that consumption of milk is associated with a dose-dependent increase in the risk of people carrying antimicrobial-resistant E coli. The mechanism appears to be mostly associated with consumption of antibiotic-resistant bacteria in milk.
Implications of all the available evidence
Local, national, and global policies and plans that emphasise the importance of antibiotic stewardship rather than bacterial transmission might have little near-term effects on the prevalence of antibiotic-resistant bacteria in low-income countries. Because of funding constraints and difficulties in drug regulation in these countries, interventions that promote behavioural changes that limit transmission, including practices related to hygiene and sanitation, should be prioritised. Many of these practices will be culturally framed (eg, through ethnomedical belief systems), ensuring that attention should be given to the social context in which antimicrobial-resistant organisms are favoured and transmitted.
To better understand the complexity and interactions of factors driving antimicrobial resistance across pastoralist and impoverished communities in low-income and middle-income countries, we aimed to identify risk factors associated with the carriage of resistant Escherichia coli in three ethnic groups in northern Tanzania.
Methods
Cultural background
We did a mixed-methods study that combined extensive ethnographic observations with collection of biological samples to identify factors associated with carriage of antimicrobial-resistant E coli in Chagga highland farmers, Maasai pastoralists, and Arusha agropastoralists in Tanzania (appendix). These communities vary considerably across social dimensions that have been routinely proposed as potential risk factors for antimicrobial resistance (appendix),10 including education and income levels, antimicrobial use and access, animal husbandry practices, proximity to urban environments, and hygiene and sanitation practices. However, the Chagga, Maasai, and Arusha also live in close proximity to each other, such that households buy and sell livestock and crops at the same markets, visit the same hospitals and pharmacies, and deal with the same regulations and policies that guide human and animal health care in Tanzania. Differences between communities could drive differences in the prevalence of antimicrobial resistance, but it is possible that interactions between communities will diminish the effects of cultural and ecological differences.
Chagga farmers live on the slopes of Mount Kilimanjaro in close proximity to the major urban centre of Moshi, which has a population of around 200 000 people. Most Chagga households rely on mixed agriculture, with small zero-grazing (ie, animals are confined to pens and brought fodder and water) herds of small stock (ie, sheep and goats; mean number of animals=4) and cattle (mean number of animals=1·5).10 Other Chagga households derive most of their income from waged and salaried jobs in Moshi and surrounding areas,11 and rely on professional veterinary care. Almost every Chagga household (96%) reported adherence to antibiotic-withdrawal periods before consumption of meat and milk.10 Approximately 92% of Chagga household heads have received some formal education.10
Maasai pastoralists live throughout Tanzania and Kenya.12, 13, 14 Most Maasai supplement their main herding livelihoods by growing crops (mostly maize and beans).12 In the six Maasai villages surveyed (appendix), households had a mean of 84 cattle and 142 small stock.10 More than 70% of Maasai household heads had no formal education.10 Most Maasai households (74%) regularly diagnose disease in their animals and administer veterinary medicines without veterinary supervision, and most people (93%) were unlikely to adhere to withdrawal periods after giving veterinary antibiotics to their animals.10
Arusha agropastoralists inhabit the periurban areas surrounding Arusha, a major municipality in northern Tanzania with a population of around 420 000. Arusha tend to combine smallholder cultivation of beans, bananas, and coffee with small-scale livestock keeping.15 In the five Arusha villages surveyed, small-stock herds contained a mean of six animals and cattle herds contained a mean of two animals.10 30% of household heads had no formal education.10 Shared history with the Maasai could account for why 40% of Arusha households administer antibiotics to their animals without veterinary supervision, even though their subsistence patterns, access to modern veterinary services, and distance to urban areas are more similar to those of the Chagga.10, 15 Only 28% of Arusha reported adherence to veterinary antibiotic-withdrawal guidelines.10
Procedures
A mixed-methods, qualitative and quantitative approach was used to develop the survey instrument, which included 226 items (appendix). To measure antibiotic use, we included self-reported indicators of lay use, health-care visits, the number of antibiotics or packages in the household, and ownership of syringes and needles. Previous work showed that a combination of self-reported and direct observation offered a robust scale of antimicrobial use (appendix).10 The study was reviewed and approved by the Washington State University (IRB12355) and Tanzania National Institute for Medical Research institutional review boards, and then the Tanzania Commission for Science and Technology subsequently issued a research permit (permit 2012-151).
We purposefully selected 13 villages on the basis of ethnic composition and distance to urban centres (which could affect prevalence of antimicrobial resistance;16, 17, 18 appendix). Although villages were purposefully chosen, households were randomly selected from census lists provided by local offices. Surveys were administered to the household head by research assistants who were fluent in English, Swahili, and Maa or Chagga, and who received 1 month of training. We collected human stool samples when available at the households. We also started to collect liquid milk and swabs of milk containers from Maasai and Arusha households after initial results suggested a possible association between antimicrobial resistance and milk consumption.
Samples were placed into a portable 12v refrigerator set at 5°C and were transported to the Nelson Mandela African Institution of Science and Technology (Arusha, Tanzania), within 48 h of collection. Faecal samples were diluted in sterile water (1:10 weight per volume). Swab suspensions were made by squeezing swabs inside a whirl-pack with 5 mL of sterile water. Samples and milk were then plated onto MacConkey agar plates using sterile glass beads and were incubated overnight at 37°C. Up to 48 presumptive isolates per sample were selected on the basis of colony morphology that was consistent with E coli. This number of isolates provides a greater than 50% probability of detecting at least one isolate with resistance to a given antibiotic when that population of resistant bacteria makes up only 2% of isolates in the sample. Isolates were inoculated individually into the wells of 96-well assay plates containing 150 μL per well of Luria broth. Approximately 40 μL of these cultures were transferred to new 96-well plates, air-dried, and shipped to Washington State University (Pullman, WA, USA) for antimicrobial-susceptibility testing. Serial plating onto MacConkey agar plates was used to estimate the bacterial load (log10) of lactose-fermenting bacteria per mL of milk.
Susceptibility to nine antimicrobials was measured with a breakpoint assay. Briefly, MacConkey agar was prepared with fixed concentrations of the antibiotics ampicillin (32 μg/mL), ceftazidime (8 μg/mL), chloramphenicol (32 μg/mL), ciprofloxacin (4 μg/mL), kanamycin (64 μg/mL), streptomycin (16 μg/mL), sulfamethoxazole (512 μg/mL), tetracycline (16 μg/mL), or trimethoprim (8 μg/mL). Concentrations were guided by the Clinical and Laboratory Standards Institute minimum inhibitory concentrations for Enterobacteriaceae.19 Shipped bacteria were recovered from a desiccated state by adding 150 μL Luria broth, followed by stationary incubation overnight (37°C). We used a 96-pin replicator to transfer culture (approximately 2 μL) onto agar media plates, which were subsequently incubated overnight. A positive (resistant) and negative (sensitive) control strain of E coli was added to every plate. Cultures that grew full colonies were considered to be antibiotic resistant. Cultures for which there was little to no growth were scored as antibiotic sensitive.
To investigate whether single boiling events can affect the biological activity of oxytetracycline residues in milk, different concentrations of oxytetracycline were added to aliquots of milk that were subsequently heated to boiling temperature for 2–3 min. After cooling to room temperature, oxytetracycline-resistant or oxytetracycline-susceptible E coli cultures (isogenic strains) were added to each aliquot (6 log10 colony-forming units per mL per strain). These cultures were then incubated at 37°C for 24 h, after which the numbers of colony-forming units of resistant and susceptible E coli were enumerated on MacConkey agar plates to establish which strain dominated the culture (appendix).
Statistical analysis
To identify the risk factors associated with antimicrobial resistance, we compiled a set of 56 variables from our household surveys (appendix) that detailed health-care practices and human and livestock antibiotic use. These variables have been previously proposed or identified as risk factors for antimicrobial resistance.2, 3, 4, 5, 6, 7, 8, 9, 10 Random Lasso regressions20 (appendix) were used to identify variables associated with resistance to one of the five most prevalent antimicrobial-resistance phenotypes (ampicillin, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim) or with resistance to three or more antibiotics (multidrug resistance; appendix). The Lasso regressions functioned as a variable-selection process, which reduced the original 56 variables to a subset of variables (appendix) that were consistently related to antimicrobial resistance. Variables that were excluded by the Lasso regressions were considered not to be significant. Variable subsets were then entered into mixed-effects logistic regression models (clustered at the household). We calculated odds ratios (ORs) for the best-fit models (assessed with the Akaike information criterion).
Role of the funding source
The study funders had no role in study design; data collection, analysis, or interpretation; or writing of the report. The corresponding author had full access to all study data and had final responsibility for the decision to submit for publication.
Results
Between March 23, 2012, and July 30, 2015, we interviewed 391 households (118 Arusha, 100 Chagga, and 173 Maasai). Human stool samples were collected at 226 (58%) households across the 13 villages (three Arusha, four Chagga, and six Maasai). 181 milk samples and 191 milk-container swabs were collected from 117 households across seven villages (three Arusha and four Maasai).
11 470 putative E coli samples were isolated from stool samples (appendix). The mean prevalence of resistance to the nine antimicrobials tested for was highest for Maasai and Arusha households, and lowest for Chagga households (figure 1). The prevalence of resistance to ampicillin, tetracycline, trimethoprim, sulfamethoxazole, and streptomycin was consistently higher than that to other tested antibiotics across all groups (figure 1). The diversity of resistance phenotypes was similar across groups (appendix).
For the Chagga, no factor was significantly associated with the odds that bacteria would be resistant to more than one antimicrobial (appendix). Households reporting that they “interrupted their business” (eg, stopped going to work) to care for sick livestock were less likely to carry tetracycline-resistant E coli than those reporting no interruption (OR 0·34 [95% CI 0·14–0·66]). An increased number of water sources used for livestock was associated with an increased likelihood of trimethoprim resistance (1·89 [1·10–2·78]). Arusha households that shared water sources with livestock and wildlife were far more likely to carry multidrug-resistant E coli (7·54 [2·41–23·45]), and E coli resistant to sulfamethoxazole (9·23 [3·19–26·75]), streptomycin (11·70 [2·74–50·01]), and tetracycline (6·23 [2·05–19·02]) than were households that shared water sources with livestock only (appendix).
For Maasai households, consumption of unboiled (raw) milk was associated with increased odds of carriage of E coli resistant to each antibiotic and of multidrug-resistant E coli (figure 2; appendix). When we compared household milk consumptions 25% below (ie, 1·1 L) the mean with those 25% above (ie, 6·0 L) the mean, the odds of detecting resistance increased from 1·48 (95% CI 1·10–2·01) to 8·67 (6·42–11·70) for ampicillin, from 1·62 (1·19–2·28) to 14·28 (10·44–19·54) for streptomycin, from 1·75 (1·26–2·42) to 21·33 (15·46–29·43) for sulfamethoxazole, from 1·56 (1·17–2·10) to 11·70 (8·74–15·70) for tetracycline, from 1·52 (1·12–2·07) to 9·94 (7·29–13·57) for trimethoprim, and from 1·54 (1·16–2·02) to 10·38 (7·89–13·66) for multidrug resistance. Assuming that increased antibiotic use translates into a higher prevalence of antimicrobial-resistant bacteria,1 then the strong correlation between antimicrobial resistance and consumption of raw milk in the Maasai could be explained by increasing milk-borne illness and subsequent antibiotic use. Indeed, Maasai families frequent health clinics 11% more often than Arusha families, and 27% more often than Chagga families.10 Nevertheless, our Lasso variable-selection process showed no consistent relationship between antimicrobial use and the odds of finding antimicrobial-resistant E coli in Maasai stool samples (appendix).
The relationship between milk and antimicrobial resistance could also be because of consumption of antibiotic-resistant bacteria in contaminated milk. 73 (63%) of 115 milk samples from 59 Maasai households and 37 (71%) of 52 samples from 31 Arusha households had counts of lactose-fermenting bacteria (including E coli) between 102 and 106 per mL (figure 3A). Although E coli is lactose-fermenting, the proportion of E coli in these samples was low (21·7% in milk samples, and 9·5% in milk-container swabs; appendix). Nevertheless, when we compared E coli isolates that were confirmed by DNA sequencing with other lactose-fermenting bacteria (Enterobacter spp and Klebsiella spp; appendix), there was a high correlation (r2=0·92) in terms of the prevalence of resistance to all nine antibiotics. There was also a strong correlation between the proportion of antimicrobial-resistant lactose-fermenting bacteria detected in milk samples (figure 3B) and stool samples for household-matched samples (figure 4A; appendix). Resistance to several antibiotics was more prevalent in lactose-fermenting bacteria isolated from Maasai milk samples than in those isolated from Arusha milk samples (figure 3B).
The higher proportion of antimicrobial-resistant lactose-fermenting bacteria in Maasai milk could have arisen from the presence of antibiotic residues in the milk, because 93% of Maasai households do not adhere to withdrawal times for veterinary antibiotics, compared with 28% of Arusha households and 4% of Chagga households.10 We did not measure concentrations of antibiotic residues, but the prevalence of antimicrobial-resistant lactose-fermenting bacteria in milk was 5–10% lower for households that consistently adhered to withdrawal times compared with those that were willing to consume contaminated milk (figure 4B) and for households that used more antibiotics compared with those who used less (appendix), and 3–5% lower (except for ceftazidime) for households that did not consume milk from sick cows that might have been treated with antibiotics compared with those that did (appendix). Despite this association, adherence to antibiotic-withdrawal periods before milk consumption did not significantly affect prevalence according to our Lasso regression procedure (appendix). If there were a drug-residue effect, it would most likely be associated with oxytetracycline, because approximately 80% of Maasai households report recent use of this antibiotic.10 If the bioavailability of oxytetracycline was reduced by boiling milk, this would strengthen the possible relationship with consumption of raw milk. According to our results, boiling milk was unlikely to reduce the bioavailability of oxytetracycline residues (appendix). Nevertheless, for households that adhered to withdrawal periods, approximately 30% of milk samples were positive for tetracycline-resistant lactose-fermenting bacteria (figure 4B). For households that did not adhere to withdrawal periods, approximately 53% of the milk samples were tetracycline-resistant lactose-fermenting bacteria (figure 4B).
Discussion
In this mixed-methods study, we showed that, although the relative patterns of resistance to nine antibiotics in E coli carried by Chagga, Arusha, and Maasaia peoples in northern Tanzania are generally similar, there are substantial differences in prevalence across the three groups, which are linked to group-specific risk factors. Contrary to conventional expectations, differences in prevalence were not associated with antibiotic use in animals or people but were instead associated with culturally informed practices that affect bacterial transmission, including livestock management and food preferences. Our results emphasise that efforts to address antimicrobial resistance globally will require approaches that address the drivers of resistance within the cultural context of communities.
The prevalence of E coli resistant to ampicillin, tetracycline, trimethoprim, sulfamethoxazole, or streptomycin, all of which are used in human medicine, was high in Maasai and Arusha households. Although the breakpoint assay that we used is different from the clinical microbiology assays used in many other studies of antimicrobial resistance studies, our findings are similar to those of other studies in low-income settings. For example, community sampling in Peru found similar proportions of E coli resistant to ampicillin (62·6%), cotrimoxazole (48·6%), tetracycline (43·0%), and chloramphenicol (15·8%).6, 21, 22 These community-level estimates are based on randomly selected samples and we should expect these estimates to be lower than estimates from non-random, clinical datasets.21 For example, Shigella spp, Salmonella spp, and E coli isolated from children presenting with acute diarrhoea in western Kenya were highly resistant to ampicillin (81·3%), tetracycline (75·0%), and cotrimoxazole (92·8%).5
Neither human nor veterinary antibiotic use was a significant predictor of the carriage of antimicrobial-resistant E coli in any ethnic group. This finding does not mean that antibiotic use has no effect, but rather that practices affecting transmission were more important drivers of the prevalence of resistance. Water was a risk factor for both Chagga and Arusha. For Chagga households, each additional water source for livestock increased the chances of people having trimethoprim-resistant E coli. Bacteria with similar resistance patterns to those in this study were found in waters in the same area in another study.22 Chagga usually access drinking water from sources without animal contact, and thus the association with livestock water access could reflect contact transmission at the household level. The odds of carrying resistant E coli was increased when Arusha households shared water sources with larger livestock herds and wildlife, which probably reflects both contact and water-mediated transmission to people.
For Maasai households, the association between antimicrobial-resistant E coli and volume of milk consumption was consistent across the analysed resistance phenotypes. Importantly, although there was an association between carriage of these bacteria and antimicrobial-resistant bacteria in Arusha milk, milk consumption was not an important factor for Arusha households. This finding probably relates to the fact that Maasai households consume substantially more milk daily (mean 3·92 L) than do Arusha (1·67 L) or Chagga households (1·20 L). Consumption of raw milk is a risk factor for disease transmission,23 and thus it is also likely to be a source for transmission of antimicrobial-resistant bacteria (whether pathogenic or not). Pathogen transmission could lead to greater demand for antibiotics by people, although our self-reported data did not show this association.
The mechanism underlying the association between milk and antimicrobial resistance appears to be related to basic transmission. This association has important implications for low-income countries, where potable water remains a pressing challenge,24 consumption of dairy products is increasing, and most milk is produced and distributed through informal sources that operate outside national quality-control standards and regulations.21 More than 60% of milk samples that we tested had up to 6 log10 mL bacteria, and the distribution of resistance phenotypes was similar to that in stool samples for both milk and swabs of milk-storage containers (Figure 3, Figure 3; appendix). Antibiotic withdrawal could contribute to this pattern if residues are present in milk. Our ability to detect a statistical association was limited in Maasai households because only 7% adhered to the recommended antibiotic-withdrawal period. There was more variation in Arusha households, with 72% adhering to recommended withdrawal periods. Nevertheless, for oxytetracycline, the most common veterinary antibiotic in use, the pattern was the opposite of what would be predicted, with approximately 30% of lactose-fermenting bacteria isolates resistant to tetracycline when antibiotic withdrawal was not adhered to and roughly 53% of isolates resistant when households adhered to withdrawal guidelines. It is possible that drug residues could be consumed and select for resistant bacteria in people, but concentrations in milk rarely exceed 1 part per million for oxytetracycline,25 and dilution, adsorption, and dissipation are likely to further limit the potential effect on the gut flora of the person ingesting the milk. Finally, although there is some evidence for possible withdrawal effects (figure 4B), this effect is quite small compared with the effects of milk consumption. For example, consuming 1 L of milk containing 4 log10 bacteria per mL translates into an inoculum of 10 million bacteria, many of which harbour resistance to antimicrobials.
As a result, the most probable mechanism underlying the raw milk association is dose-dependent oral transmission. Why antimicrobial-resistant bacteria are found in milk in remotely located pastoral communities is worth examining. Veterinary antibiotics could have a role in this process, but the sporadic nature of their use relative to a potential equilibrium of resistance in the population could confound attempts to establish a statistical relationship. Nevertheless, we surmise that sporadic antibiotic use, when coupled with non-adherence to antibiotic-withdrawal periods and poor hygiene and sanitation, leads to periodic amplification of resistant bacteria in milk and milk-storage vessels. Because resistance traits rarely induce a substantial fitness cost,26 resistant and susceptible bacteria are generally equally competitive, and therefore only sporadic amplification (or introductions from outside sources) might be needed to maintain a high prevalence of resistant bacteria in a population.
Our study has several limitations. Self-reported data can be inaccurate because of recall and social desirability biases, which, if biased by ethnic group, could lead to spurious correlations.27 Furthermore, like any cross-sectional study, correlations cannot prove causation because unmeasured variables could be covarying with the ones that we used in the analysis. For example, when we pooled data across all households, ethnic group was the strongest predictor of differences in the prevalence of resistance (appendix). This finding was consistent with the shared cultural history within groups representing the aggregate driver of differences between groups. Important aspects of this shared history probably include patterns of antibiotic use, disease, food traditions, and animal–human connectivity that combine to establish different baseline levels of resistance. In view of the contribution of this shared history, we used separate models for each ethnic group. Additionally, although risk factors for antimicrobial resistance in the Arusha and Maasai were associated with multiple antibiotics, the few risk factors in the Chagga were only associated with one antibiotic, which increases the chance for spurious associations. The microbiology methods used in this study were the most practical given logistic realities,28 but we acknowledge that identification of E coli by colony morphology only could lead to misidentification. In an associated whole-genome-sequencing project based on a subset of bacteria from this study, 9% of isolates from human stool samples presumed to be E coli were actually Enterobacter or Klebsiella species (appendix). Importantly, we found no evidence that there was bias in the distribution of these misidentified strains, and the correlation between resistance phenotypes for E coli and non-E coli isolates was very high (r2 =0·92).
In conclusion, the primary predictors of the prevalence of antimicrobial resistance in three Tanzanian groups were related to transmission rather than direct selection for resistant bacteria. Our findings emphasise the need to devote more resources to improvement of hygiene and sanitation, which has been acknowledged as a “neglected aspect in the fight against antimicrobial resistance”.29 Furthermore, antimicrobial resistance should be treated as much as a cultural challenge as as a medical one because interventions in low-income and middle-income communities need to target behaviours that affect transmission, some of which will be culture specific. Without careful consideration of the local proximate drivers of transmission, such as milk handling and livestock practices, WHO-inspired national antimicrobial-resistance plans will probably have little effect on resistance in low-income and middle-income countries, where more than 80% of the world's population reside.
Acknowledgments
Acknowledgments
This study was funded by the US National Science Foundation (grant number DEB 1216040), the UK Biotechnology and Biological Sciences Research Council (grant numbers BB/K01126X/1 and BB/L018926/1), the UK Medical Research Council (grant number MC_UU_12014/9), and the Allen School. We are grateful for the invaluable assistance of many people, including Chagga, Arusha, and Maasai study participants, the village chairmen of focal villages (Isaya Rumas, Godfrey Naisikye, Lemuta Naisikye, Imma Laiser, Willium Kanunga, Imani Baraka, Paul Sangre, Joseph Tarimo, Joseph Temo, Rigobert Tarimo, and Deogratius Mshanga), and the Nelson Mandela African Institution of Science and Technology, which provided invaluable logistical support.
Contributors
LM, RJQ, MBQ, and DRC designed the study. MAC, MS, RJQ, MBQ, and DRC planned and completed data collection. MS did the laboratory analysis and MAC and CM did the statistical analyses. MAC, CM, MS, LM, and DRC wrote the first draft of the Article, which was revised and critically reviewed by all other authors.
Declaration of interests
We declare no competing interests.
Supplementary Material
References
- 1.Holmes AH, Moore LS, Sundsfjord A. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187. doi: 10.1016/S0140-6736(15)00473-0. [DOI] [PubMed] [Google Scholar]
- 2.WHO . World Health Organization; Geneva: 2015. Global action plan on antimicrobial resistance. [DOI] [PubMed] [Google Scholar]
- 3.Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20:533–539. doi: 10.3122/jabfm.2007.06.070019. [DOI] [PubMed] [Google Scholar]
- 4.MacPherson DW, Gushulak BD, Baine WB. Population mobility, globalization, and antimicrobial drug resistance. Emerg Infect Dis. 2009;15:1727. doi: 10.3201/eid1511.090419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brander RL, Walson JL, John-Stewart GC. Correlates of multi-drug non-susceptibility in enteric bacteria isolated from Kenyan children with acute diarrhea. PLoS Negl Trop Dis. 2017;11:e0005974. doi: 10.1371/journal.pntd.0005974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kalter HD, Gilman RH, Moulton LH, Cullotta AR, Cabrera L, Velapatiño B. Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study. Am J Trop Med Hyg. 2010;82:879–888. doi: 10.4269/ajtmh.2010.09-0143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kristiansson C, Grape M, Gotuzzo E. Socioeconomic factors and antibiotic use in relation to antimicrobial resistance in the Amazonian area of Peru. Scand J Infect Dis. 2009;41:303–312. doi: 10.1080/00365540902783301. [DOI] [PubMed] [Google Scholar]
- 8.Seidman J, Kanungo R, Bourgeois A, Coles C. Risk factors for antibiotic-resistant E coli in children in a rural area. Epidemiol Infect. 2009;137:879–888. doi: 10.1017/S0950268808001519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mathai E, Chandy S, Thomas K. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in Southern India. Trop Med Int Health. 2008;13:41–45. doi: 10.1111/j.1365-3156.2007.01969.x. [DOI] [PubMed] [Google Scholar]
- 10.Caudell MA, Quinlan MB, Subbiah M. Antimicrobial use and veterinary care among agro-pastoralists in northern Tanzania. PLoS One. 2017;12:e0170328. doi: 10.1371/journal.pone.0170328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Campbell DJ, Misana SB, Olson JM. Comparing the Kenyan and Tanzanian slopes of Mt Kilimanjaro: why are the neighbouring land uses so different? http://www.lucideastafrica.org/publications/Campbell_LUCID_WP_44.pdf
- 12.McCabe JT, Leslie PW, DeLuca L. Adopting cultivation to remain pastoralists: the diversification of Maasai livelihoods in northern Tanzania. Hum Ecol. 2010;38:321–334. doi: 10.1007/s10745-010-9312-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Roth EA, Fratkin E. Kluwer; New York, NY: 2005. As pastoralists settle: social, health, and economic consequences of the pastoral sedentarization in Marsabit District, Kenya. [Google Scholar]
- 14.Hodgson DL. Indiana University Press; Bloomington, IN: 2001. Once intrepid warriors: gender, ethnicity, and the cultural politics of Maasai development. [Google Scholar]
- 15.Spear T. University of California Press; Berkeley, CA: 1997. Mountain farmers: moral economies of land and agricultural development in Arusha and Meru. [Google Scholar]
- 16.Walson JL, Marshall B, Pokhrel BM, Kafle KK, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J Infect Dis. 2001;184:1163–1169. doi: 10.1086/323647. [DOI] [PubMed] [Google Scholar]
- 17.Najjuka CF, Kateete DP, Kajumbula HM, Joloba ML, Essack SY. Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda. BMC Res Notes. 2016;9:235. doi: 10.1186/s13104-016-2049-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Eisenberg JNS, Goldstick J, Cevallos W. In-roads to the spread of antibiotic resistance: regional patterns of microbial transmission in northern coastal Ecuador. J R Soc Interface. 2012;9:1029–1039. doi: 10.1098/rsif.2011.0499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Clinical and Laboratory Standards Institute . 24th edn. Clinical and Laboratory Standards Institute; Wayne, PA: 2014. Performance standards for antimicrobial susceptibility testing. [Google Scholar]
- 20.Park H, Imoto S, Miyano S. Recursive random lasso (RRLasso) for identifying anti-cancer drug targets. PLoS One. 2015;10:e0141869. doi: 10.1371/journal.pone.0141869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Williams PCM, Isaacs D, Berkley JA. Antimicrobial resistance among children in sub-Saharan Africa. Lancet Infect Dis. 2018;18:e33–e44. doi: 10.1016/S1473-3099(17)30467-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lyimo B, Buza J, Subbiah M, Smith W, Call DR. Comparison of antibiotic resistant Escherichia coli obtained from drinking water sources in northern Tanzania: a cross-sectional study. BMC Microbiol. 2016;16:254. doi: 10.1186/s12866-016-0870-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Costard S, Espejo L, Groenendaal H, Zagmutt FJ. Outbreak-related disease burden associated with consumption of unpasteurized cow's milk and cheese, United States, 2009–2014. Emerg Infect Dis. 2017;23:957. doi: 10.3201/eid2306.151603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dangour AD, Watson L, Cumming O. Interventions to improve water quality and supply, sanitation and hygiene practices, and their effects on the nutritional status of children. Cochrane Database Syst Rev. 2011;8 doi: 10.1002/14651858.CD009382.pub2. CD009382. [DOI] [PubMed] [Google Scholar]
- 25.Seymour E, Jones G, McGilliard M. Persistence of residues in milk following antibiotic treatment of dairy cattle. J Dairy Sci. 1988;71:2292–2296. doi: 10.3168/jds.S0022-0302(88)79806-9. [DOI] [PubMed] [Google Scholar]
- 26.Hinrichs W, Kisker C, Duvel M. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science. 1994;264:418–420. doi: 10.1126/science.8153629. [DOI] [PubMed] [Google Scholar]
- 27.Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016;9:211–217. doi: 10.2147/JMDH.S104807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Omulo S, Lofgren ET, Mugoh M. The impact of fecal sample processing on prevalence estimates for antibiotic-resistant Escherichia coli. J Microbiol Methods. 2017;136:71–77. doi: 10.1016/j.mimet.2017.03.006. [DOI] [PubMed] [Google Scholar]
- 29.The Lancet Global Health Fighting antimicrobial resistance on all fronts. Lancet Glob Health. 2017;5:e1161. doi: 10.1016/S2214-109X(17)30432-1. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.